BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 7, 2015
View Archived Issues
Novel sedative compares favorably with propofol in dogs
Read More
Janssen's gamma-secretase modulator effective in AD models
Read More
AAV-mediated gene delivery shows promising results in AD models
Read More
New results presented for lapatinib in the treatment of recurrent ependymoma
Read More
Daiichi Sankyo receives approval in Japan for methylene blue
Read More
China organizations disclose analgesic frog skin oligopeptide
Read More
Merck & Co. reports new HIV integrase inhibitors
Read More
Kaken discloses novel EP4 receptor antagonists
Read More
Astellas presents compounds for breast cancer
Read More
Helix BioMedix patents human C-X-C chemokine-derived peptides
Read More
Innovate Biopharmaceuticals to acquire RG-1068 assets
Read More
Vectura to apply its inhaled drug delivery technology to Janssen asthma and COPD candidates
Read More
Minerva Neurosciences' neuregulin-1 analogue shows activity in primate model of Parkinson's disease
Read More
FDA approves Gadavist as contrast agent for pediatric patients under age 2
Read More
Phase III trial of perampanel in refractory partial-onset seizures meets primary endpoint
Read More
Manufacturing and distribution approval for selective SGLT2 inhibitor for diabetes
Read More
CytRx reports interim results from phase II trial of aldoxorubicin in GBM
Read More
BrainStorm Cell Therapeutics reports final results from phase IIa ALS study of NurOwn
Read More
Alnylam files application for phase I trial of ALN-AS1
Read More
Cenicriviroc receives FDA Fast Track designation
Read More
FDA awards fast track designation to IMMU-132 for triple-negative breast cancer
Read More
Sirnaomics files Chinese IND application for STP-705 for hypertrophic scars
Read More
Taiho files Japanese NDA for Yondelis in soft tissue sarcoma
Read More
European orphan drug designation for Kite Pharma's KTE-C19 for DLBCL
Read More
FDA grants orphan drug status to selinexor for multiple myeloma
Read More
Celiprolol receives FDA orphan drug status for Ehlers-Danlos syndrome
Read More